<DOC>
	<DOCNO>NCT01080469</DOCNO>
	<brief_summary>The objective study demonstrate bioequivalence Test Product ( A ) : Tacrolimus Capsules 1 mg , manufacture Panacea Biotec Limited , India correspond Reference Product ( B ) : Prograf ( Tacrolimus ) Capsules 1 mg , manufacture Astellas Pharma , Inc. , USA 36 normal , healthy , adult , male subject feed condition .</brief_summary>
	<brief_title>Bioequivalence Study Tacrolimus 1 mg Capsule Under Fed Condition</brief_title>
	<detailed_description>Total 36 normal healthy adult male subject enrol study . Subjects administer either Test Reference Product 240 mL water period per randomization schedule . Subjects fast least 10 hour prior High Fat Breakfast half hour administration study drug four ( 4 ) additional hour , post dose study period . Standardized meal provide study period . Water accessible subject 1 hour Predose 2 hour Post dose period . A total 26 blood sample withdraw pharmacokinetic profiling . The whole blood concentration Tacrolimus measure validated LC/MS/MS analytical method . Ratio analysis perform untransformed log transform pharmacokinetic parameter Cmax , AUC0-72 , AUC0 inf . ANOVA perform log transform pharmacokinetic parameter Cmax , AUC0-72 , AUC0-inf 90 % confidence interval construct ratio geometric least square mean Test Reference product , obtain log-transformed data . Bioequivalence conclude ratio estimate well 90 % confidence interval , fall within acceptable range 80.00 % 125.00 % Cmax , AUC0-72 AUC0-inf .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>1 . Male subject range age 18 55 year . 2 . Body weight within Â± 15 % ideal weight relate height body frame accord Life Insurance Corporation ( LIC ) Chart . ( Appendix A ) 3 . Subjects normal finding determine baseline history , physical examination vital sign ( blood pressure , pulse rate , respiration rate axillary temperature ) . 4 . Subjects normal finding determine Haemogram ESR , Biochemistry , Infectious Disease Screening ( HIV , Hepatitis B Hepatitis C ) Urinalysis , ECG , Xray ( Xray take ) . 5 . Willingness follow protocol requirement evidence write , informed consent . 6 . Agreeing , use medication prescription counter medication include vitamin mineral 14 day prior study &amp; course study . 7 . No history presence significant alcoholism drug abuse past one year . 8 . Nonsmokers , ex smoker moderate smoker include . `` Moderate smoker define someone smoking 10 cigarette less per day , ex smoker someone completely stop smoke least 3 month . '' 1 . Requiring medication ailment include enzymemodifying drug previous 28 day , day 1 dosing . 2 . Any medical surgical condition , might significantly interfere function gastrointestinal tract , bloodforming organ etc . 3 . History presence cardiovascular , renal , hepatic , ophthalmic , pulmonary , neurological , metabolic , haematological , gastrointestinal , endocrine , immunological psychiatric disease . 4 . Participation clinical drug study bioequivalence study 90 day prior present study . 5 . History presence malignancy serious disease . 6 . Refusal abstain food least ten ( 10 ) hour prior administration study drug four ( 4 ) additional hour , post dose study period . 7 . Any contraindication blood sampling . 8 . Refusal abstain water least one ( 1 ) hour prior study drug administration dose day study period least two ( 2 ) additional hour , post dosing except 240 mL administer administration dose . 9 . Use xanthinecontaining beverage food grapefruit grapefruit product 48 hour prior drug dose . 10 . Blood donation 90 day prior commencement study . 11 . Subjects positive HIV test , HBsAg HepatitisC test . 12 . Subjects contradiction hypersensitivity Tacrolimus relate group drug excipients product . 13 . Refusal abstain smoke consumption tobacco product 24 hour dose last sample collection period . 14 . Found positive Breath alcohol test do time screen day enrollment study period every ambulatory sample . 15 . History presence problem swallow tablet capsule .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Bioequivalence study healthy volunteer</keyword>
</DOC>